Post-traumatic stress disorder (PTSD) biomarkers have been identified in the blood samples of...
FDA clears GE’s AI algorithms to identify pneumothorax
The US Food and Drug Administration (FDA) has granted 510(k) clearance to GE Healthcare’s artificial intelligence (AI) algorithms, Critical Care Suite, to identify pneumothorax, a type of collapsed lung.
Healthy.io gets FDA clearance for mobile-based CKD test
Israeli diagnostic solutions developer Healthy.io has received 510(k) clearance from the US Food and Drug Administration (FDA) for the use of its smartphone-based albumin / creatinine ratio (ACR) test to diagnose chronic kidney disease (CKD).
Abbott’s AI solution helps detect heart attack in hospitals
A clinical study by Abbott has shown that its artificial intelligence (AI) technology can accurately identify patients having a heart attack in emergency rooms.
AI-powered blood test identifies PTSD in early study
Post-traumatic stress disorder (PTSD) biomarkers have been identified in the blood samples of veterans with 77% accuracy using an artificial intelligence (AI) tool.
Oncimmune’s test helps detect lung cancer prematurely in clinical trial
Immunodiagnostics firm Oncimmune has reported positive results from a randomised clinical trial, ECLS, which assessed its EarlyCDT Lung cancer detection test.
OncoCyte agrees to acquire stake in Razor Genomics
Cancer diagnostic tests developer OncoCyte has signed a definitive agreement to acquire 25% of the outstanding shares of Razor Genomics, which offers treatment stratification test for lung cancer.
August’s top news stories
Google division DeepMind has partnered with the US Department of Veterans Affairs to develop an AI tool that could predict acute kidney injury up to 48 hours in advance, and Siemens Healthineers has signed a definitive agreement to acquire all fully diluted shares of US-based Corindus Vascular Robotics. Medicaldevice-network.com wraps up key headlines from August 2019.
World-first cardio trial shows reduced wait times and hospital admissions
Researchers from Flinders University in Australia have conducted a new clinical trial to assess the use of a new acute coronary syndrome screening protocol using a cardiac blood test.
SkylineDx secures funding for melanoma diagnostic test
Dutch biotech company SkylineDx has received €20m ($21.9m) funding from Benelux investor Aat van Herk for a skin cancer diagnostic test.
Urine test shows promise for cancer detection in lab study
A laboratory study in mice demonstrates that a colour-change urine test based on nanosensors could help detect colon cancer / bowel cancer.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.